The increasing hospital disease burden of haemochromatosis in England

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 2, 2010, Pages 247-252

  Cowan, M L ^a   Westlake, S ^b   Thomson, S J ^a   Rahman, T M ^a   Majeed, A ^c   Maxwell, J D ^a   Kang, J Y ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CHILD; FEMALE; GENDER; HEMOCHROMATOSIS; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; ENGLAND; FEMALE; HEMOCHROMATOSIS; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 72949091837     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04168.x     Document Type: Article

References (24)

1. Thomson SJ, Westlake S, Rahman TM, et al. Chronic liver disease - an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease. Alcohol Alcohol 2008 43 : 416 422.
2. Roberts SE, Goldacre MJ, Yeates D. Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999. Gut 2005 54 : 1615 1621.
3. Adams PC, Barton JC. Haemochromatosis. Lancet 2007 370 : 1855 1860.
4. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996 13 : 399 408.
5. Bomford A, Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med 1976 45 : 611 623.
6. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985 313 : 1256 1262.
7. Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008 358 : 221 230.
8. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G - > A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002 359 : 211 218.
9. Brown AS, Gwinn M, Cogswell ME, Khoury MJ. Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979-1997. Genet Med 2001 3 : 109 111.
10. Milman N, Pedersen P, a Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 2001 80 : 737 744.
11. Crooks CJ, West J, Solaymani-Dodaran M, Card TR. The epidemiology of haemochromatosis - a population based study. Aliment Pharmacol Ther 2009 29 : 183 192.
12. Yu L, Ioannou GN. Survival of liver transplant recipients with hemochromatosis in the United States. Gastroenterology 2007 133 : 489 495.
13. Poullis A, Moodie SJ, Ang L, Finlayson CJ, Levin GE, Maxwell JD. Routine transferrin saturation measurement in liver clinic patients increases detection of hereditary haemochromatosis. Ann Clin Biochem 2003 40 (Pt 5 521 527.
14. Wood MJ, Powell LW, Ramm GA. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood 2008 111 : 4456 4462.
15. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis- associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998 129 : 946 953.
16. Falize L, Guillygomarc'h A, Perrin M, et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006 44 : 472 477.
17. Kuller LH. The use of existing databases in morbidity and mortality studies. Am J Public Health 1995 85 : 1198 1200.
18. Qaseem A, Aronson M, Fitterman N, Snow V, Weiss KB, Owens DK. Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2005 143 : 517 521. (Pubitemid 41377200)
19. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on haemochromatosis. J Hepatol 2000 33 : 485 504.
20. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002 122 : 281 289.
21. Nelson JE, Bhattacharya R, Lindor KD, et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 2007 46 : 723 729.
22. Williams JG, Mann RY. Hospital episode statistics: time for clinicians to get involved? Clin Med 2002 2 : 34 7.
23. Hansell A, Bottle A, Shurlock L, Aylin P. Accessing and using hospital activity data. J Public Health Med 2001 23 : 51 6.
24. Porter JB. Concepts and goals in the management of transfusional iron overload. Am J Hematol 2007 82 (Suppl 12 1136 1139.